Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thymoma × Nivolumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrent Squamous Cell Lung Carcinoma 2 Melanoma 2 Hodgkin Disease 2 Thymoma 1 Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Inoperable œsophageal Cancer 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

Taxes 2 Paclitaxel 2 Carboplatin 2 Ramucirumab 1 Proton Therapy 1 Prednisone 1 Octreotide 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03134118 2023-02-21

NIVOTHYM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡